South Korea's government drug agency cleared the way Thursday for commercial sales of what it called the world's first approved medicine using stem cells collected from other people.Having suffered a knee injury following a traffic accident in high school, I'd love to try this and see if it works.
Cartistem, developed by Seoul-based Medipost, will help regenerate knee cartilage using stem cells developed from newborns' umbilical cord blood, the Korea Food and Drug Administration said.
"Cartistem is... the world's first approved allogeneic (taken from different individuals of the same species) stem cell drug, that can offer new opportunity for treatment of patients with degenerative arthritis," the administration said in a statement.
The possibility of using stem cells to regenerate things that have degenerated is extremely promising. The brains of those suffering from Alzheimer's or Parkinson's, the spinal chord of those who have been paralyzed, various organs, etc., etc.
This is all the more promising if it can sidestep the ethical and political dilemma of using stem cells obtained from aborted fetuses.
It's a brave new world.